Search results

Page results

• World-first genotyping test that could transform care for people with sickle cell

  The NHS has become the first healthcare system in the world to provide a new blood group genotyping test which is set to transform care for patients living with sickle cell disorder and thalassaemia.

• People with aphasia make significant improvements thanks to intensive programme at UCLH

  People with the acquired communication disorder aphasia – which involves problems with the understanding or production of speech –have benefitted greatly from a two-year programme of therapy at the National Hospital for Neurology and Neurosurgery at UCLH.

• London hospitals partner up to run event for children and young people with sickle cell disorder at the Tottenham Hotspur Stadium

  North Mid, UCLH and Whittington Health are running a fun, uplifting, informative event for people with sickle cell on Saturday 25th June 2022.

• Emma Manuel Szelepet, patient governor

  Having originally studied classics, and having first worked in publishing and in the British Library, I became a lawyer and spent ten years in commercial litigation practice in the City.

• Study looking at whether COVID-19 and flu vaccines can be administered at the same time

  Researchers at UCLH have begun a study which could set the foundations for how booster COVID-19 vaccinations are delivered in the future.

• RNOH Health and Wellbeing Information and Support Sessions

  RNOH are pleased to launch a series of regular Health and Wellbeing Information and Support Sessions to support patients following a cancer diagnosis and also during/after treatment.  These…

• Infection Prevention and Control at UCLH
• Martin Jacobs, non-executive director

  Martin Jacobs joined UCLH as a non-executive director on 1 January 2020. He spent 20 years with PricewaterhouseCoopers (PwC) where he was a Partner within the Corporate Finance division.

• Neurophysiology (clinical)

  Our clinical neurophysiology department performs tests which record information from the brain or the nervous system. There are two main tests performed in our outpatient department, Electroencephalogram (EEG) and Nerve conduction studies (NCS).

• Join us in recycling Novo Nordisk pre-filled pens

  In the UK in 2020, 23 million Novo Nordisk FlexPen and FlexTouch pre-filled devices were incinerated or sent to landfill as there was no viable recycling alternative.